TITLE

Sigma-Aldrich buys Degussa's Proligo unit

PUB. DATE
March 2005
SOURCE
Chemical Business;Mar2005, Vol. 19 Issue 3, p84
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports the acquisition of Degussa's Proligo subsidiary, a provider of nucleic acids and oligonucleotide synthesis, by Sigma-Aldrich in 2005. Sales posted by Proligo in 2004; Information on Proligo.
ACCESSION #
17731638

 

Related Articles

  • Sigma-Aldrich to buy Proligo. Cozier, Muriel // European Chemical News;2/21/2005, Vol. 82 Issue 2135, p21 

    Reports that Sigma-Aldrich has agreed to buy genomics research supplier Proligo Group from Germany-based Degussa. Background of the companies; Source of the funding for the purchase.

  • Degussa Moves Into Large Oligonucleotides. Boswell, Clay // Chemical Market Reporter;10/7/2002, Vol. 262 Issue 12, p3 

    Reports that Degussa AG' fine chemicals business unit will combine the oligonucleotide business line of Proligo LLC with the cGMP custom manufacturing operations of Raylo Chemicals as of November 1, 2002. Focus of unit in providing consumables for the processing of genetic information;...

  • Sigma-Aldrich Buys Proligo for RNA Technology.  // Chemical Market Reporter;2/21/2005, Vol. 267 Issue 8, p2 

    Reports on Sigma-Aldrich Corp.'s acquisition of genomics research tools provider Proligo LLC. Significance of the move to Sigma-Aldrich; Terms of the agreement.

  • Completed Aquisition.  // Pharmaceutical Technology;May2005, Vol. 29 Issue 5, p82 

    This article reports that Sigma-Aldrich Corp. has completed its acquisition of the ProMgo Group from Degussa AG. Terms of the proposed purchase were not disclosed. Proligo had 2004 sales of approximately $40 million. Nine months of Proligo's 2005 operating results will be added to...

  • Mergers & Acquisitions Update.  // PharmaWatch: Biotechnology;Apr2005, Vol. 4 Issue 4, p20 

    The article presents mergers and acquisitions updates in the biotechnology industries. Sigma-Aldrich Corp. has acquired the Proligo Group from Degussa AG to strengthen its genomics research tools portfolio. Pfizer Inc. has agreed to acquire Idun Pharmaceuticals Inc. with a pipeline of...

  • Sigma-Aldrich completes acquisition of BioReliance.  // BioSpectrum;Mar2012, Vol. 10 Issue 3, p73 

    The article reports on the completions of the acquisition of the biopharmaceutical testing services provider BioReliance Holdings Corp. by Sigma-Aldrich Corp. in India.

  • Sigma-Aldrich Sells Its B-Line Systems To Cooper Industries. Papanikolaw, Jim // Chemical Market Reporter;04/03/2000, Vol. 257 Issue 14, p3 

    Reports the acquisition of the B-Line Systems business of Cooper Industries Inc. by Sigma-Aldrich Corp. Value of the deal; Main products of B-Line Systems; 1999 revenue of Cooper Industries.

  • Trinity to Buy Sigma's Coagulants.  // Chemical Week;7/3/2002, Vol. 164 Issue 27, p73 

    Reports on the acquisition of the coagulants product division of Sigma Aldrich by Trinity Biotech. Revenue generated by the unit for Sigma.

  • Sigma-Aldrich Acquires BioReliance for $350.  // India -- West;2/10/2012, Vol. 37 Issue 12, pB4 

    The article reports on the move of Sigma-Aldrich Corp. which acquired BioReliance Holdings Inc. for 350 million dollars from Avista Capital Partners.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics